NPPA Gene Atrial Fibrillation Type 6 NGS Genetic DNA Test - $500 USA | Comprehensive Cardiac Genetic Testing
RYR2 Gene ARVD2 NGS Genetic DNA Test - $500 USA | Comprehensive Cardiac Genetic Testing for Arrhythmogenic Right Ventricular Dysplasia RYR2 Gene Arrhythmogenic Right Ventricular Dysplasia Type 2 NGS Genetic DNA Test Original price was: $700.Current price is: $500.
SLMAP Gene Brugada Syndrome Type 9 NGS Genetic DNA Test - $500 USA | Comprehensive Cardiac Genetic Testing SLMAP Gene Brugada Syndrome Type 9 NGS Genetic DNA Test Original price was: $700.Current price is: $500.
Sale!

NPPA Gene Atrial Fibrillation Type 6 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The NPPA Gene Atrial Fibrillation Type 6 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the NPPA gene associated with familial atrial fibrillation. This comprehensive genetic analysis helps detect inherited cardiac arrhythmia conditions before symptoms appear, enabling proactive management and personalized treatment strategies. Using Next Generation Sequencing technology, the test provides precise genetic information for individuals with family histories of atrial fibrillation or unexplained cardiac symptoms. Early detection through this $500 USD test can significantly improve long-term cardiovascular health outcomes and guide appropriate medical interventions.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

NPPA Gene Atrial Fibrillation Type 6 NGS Genetic DNA Test

Comprehensive Genetic Testing for Inherited Cardiac Arrhythmias

The NPPA Gene Atrial Fibrillation Type 6 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic medicine, offering precise detection of mutations associated with familial atrial fibrillation. This advanced diagnostic tool utilizes cutting-edge Next Generation Sequencing technology to analyze the NPPA gene, which plays a crucial role in regulating heart rhythm and cardiovascular function.

What Does This Test Measure?

This specialized genetic test specifically targets the NPPA (Natriuretic Peptide A) gene, which encodes atrial natriuretic peptide – a hormone essential for maintaining proper cardiac rhythm and blood pressure regulation. The test identifies:

  • Pathogenic variants in the NPPA gene linked to atrial fibrillation type 6
  • Single nucleotide polymorphisms affecting cardiac electrical activity
  • Genetic markers associated with increased arrhythmia susceptibility
  • Inherited mutations that predispose individuals to early-onset atrial fibrillation

Who Should Consider This Test?

This genetic screening is particularly recommended for individuals experiencing:

  • Unexplained palpitations or irregular heartbeats
  • Family history of atrial fibrillation or sudden cardiac death
  • Early-onset cardiac arrhythmias without clear cause
  • Multiple family members with diagnosed atrial fibrillation
  • Recurrent syncope or dizziness of unknown origin
  • Young individuals with atrial fibrillation (under age 60)

Clinical Benefits of Genetic Testing

Undergoing the NPPA gene test provides numerous advantages for cardiovascular health management:

  • Early Risk Identification: Detect genetic predisposition before symptoms develop
  • Personalized Treatment: Guide medication selection and dosage based on genetic profile
  • Family Planning: Understand inheritance patterns for future generations
  • Proactive Monitoring: Implement targeted surveillance for at-risk individuals
  • Lifestyle Guidance: Develop personalized prevention strategies
  • Reduced Diagnostic Uncertainty: Provide definitive answers for unexplained cardiac symptoms

Understanding Your Test Results

Your genetic test results will fall into one of several categories, each with specific implications:

  • Positive Result: Indicates the presence of a pathogenic NPPA gene mutation, confirming genetic predisposition to atrial fibrillation type 6
  • Negative Result: No detected mutations in the NPPA gene, significantly reducing but not eliminating atrial fibrillation risk
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical significance requiring further evaluation
  • Carrier Status: Determines if you carry a single copy of a mutated gene that could be passed to offspring

All positive results include comprehensive genetic counseling to help you understand the implications and develop an appropriate management plan with your cardiologist.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures accessible, reliable service regardless of your location.

Take Control of Your Cardiac Health Today

Don’t wait for symptoms to develop before understanding your genetic risk for atrial fibrillation. Early detection through the NPPA Gene Atrial Fibrillation Type 6 NGS Genetic DNA Test can provide life-saving insights and enable proactive cardiovascular management.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward personalized cardiac care.

Our team of genetic counselors and cardiac specialists are ready to guide you through the testing process and help you interpret your results within the standard 3-4 week turnaround time. Remember, knowledge is power when it comes to managing inherited cardiac conditions.

SKU: cb59b747f88a Category:

Related products